2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.
To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
There are no associated biomedical information in the current reference collection.
We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate
| MeSH term | MeSH ID | Detail |
|---|---|---|
| Body Weight | D001835 | 333 associated lipids |
| Edema | D004487 | 152 associated lipids |
| Psoriasis | D011565 | 47 associated lipids |
| Arthritis | D001168 | 41 associated lipids |
| Burns | D002056 | 34 associated lipids |
| Abscess | D000038 | 13 associated lipids |
| Hypertension, Renovascular | D006978 | 10 associated lipids |
| Blood Loss, Surgical | D016063 | 6 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
| Location | Cross reference | Weighted score | Related literatures |
|---|
| Function | Cross reference | Weighted score | Related literatures |
|---|
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Mulet X et al. | High throughput preparation and characterisation of amphiphilic nanostructured nanoparticulate drug delivery vehicles. | 2010 | Int J Pharm | pmid:20580796 |
| Nguyen TH et al. | Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water soluble drugs I. Phase behaviour in physiologically-relevant media. | 2010 | J. Pharm. Pharmacol. | pmid:20636872 |
| Nguyen TH et al. | Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II. In-vivo evaluation. | 2010 | J. Pharm. Pharmacol. | pmid:20636873 |
| Gan L et al. | Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability. | 2010 | Int J Pharm | pmid:20558263 |
| Yaghmur A et al. | Effects of pressure and temperature on the self-assembled fully hydrated nanostructures of monoolein-oil systems. | 2010 | Langmuir | pmid:19681634 |
| Pandit AA and Dash AK | Surface-modified solid lipid nanoparticulate formulation for ifosfamide: development and characterization. | 2011 | Nanomedicine (Lond) | pmid:22091968 |
| Zhu Q et al. | A two-stage enzymatic process for synthesis of extremely pure high oleic glycerol monooleate. | 2011 | Enzyme Microb. Technol. | pmid:22112823 |
| Yamamura Y and Saito K | Effect of cis and trans double bonds on conformational disordering of the hydrocarbon chain of lipid, unsaturated monoacylglycerols, in the lamellar phase of a binary system with water. | 2011 | J Phys Chem B | pmid:22085247 |
| Cohen-Avrahami M et al. | Sodium diclofenac and cell-penetrating peptides embedded in H(II) mesophases: physical characterization and delivery. | 2011 | J Phys Chem B | pmid:21749044 |
| Seddon AM et al. | A highly oriented cubic phase formed by lipids under shear. | 2011 | J. Am. Chem. Soc. | pmid:21823596 |